CS6253

· Artery Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CS6253, covering 2025-05-11 to 2025-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers [EARLY_Phase 1]

See pricing